Clinical trial
Adherence to PTH(1-84) Treatment (FP-002-IM)
NCT00478569 · Takeda, Industry · Completed
Key facts
| NCT number | NCT00478569 |
|---|---|
| Title | Adherence to PTH(1-84) Treatment (FP-002-IM) |
| Official title | Adherence to PTH(1-84) Treatment in Europe. A Non-interventional Cohort Study Collecting Safety Information and Examining Reasons and Predictors for Adherence to PTH(1-84) Treatment in Usual Clinical Settings |
| Lead sponsor | Takeda, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Clinical Use of PTH(1-84) |
| Intervention type | Drug |
| Interventions | Parathyroid Hormone (PTH) (1-84) |
| Enrollment | 1,179 |
| Start date | Apr 1, 2007 |
| Primary completion | Mar 1, 2013 |
| Completion | Mar 1, 2013 |
| First posted | May 25, 2007 |
| Last update posted | May 28, 2014 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: